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We determined the antibody response against the Ixodes dammini spirochete in Lyme
disease patients by indirect immunofluorescence and an enzyme-linked immunosorbent assay
(ELISA). The specific IgM response became maximal three to six weeks after disease onset,
and then declined, although titers sometimes remained elevated during later disease. Specific
IgM levels correlated directly with total serum IgM. The specific IgG response, often delayed
initially, was nearly always present during neuritis and arthritis, and frequently remained
elevated after months ofremission. Although results obtained byindirect immunofluorescence
and the ELISA were similar, the ELISA was more sensitive and specific. Cross-reactive an-
tibodies from patients with other spirochetal infections were blocked by absorption of sera
with Borrelia hermsii, but titers of Lyme disease sera were also decreased. To further
characterize thespecificity ofthehumoral immune response against theI. damminispirochete,
"S-methionine-labeled spirochetal antigens were identified by immunoprecipitation with sera
from Lyme arthritis patients. These polypeptides had molecular weights of62, 60, 47, 37, 22,
18, and 15 kDa, and were not recognized by control sera. We conclude that the ELISA,
without absorption, is thebestmethod to assaythehumoral immune responsein Lymedisease,
and we have identified methionine-containing spirochetal polypeptides that may be important
in Lyme arthritis.
Although the Ixodes dammini spirochete, the causative agent of Lyme disease,
has been isolated from skin at the site of erythema chronicum migrans (ECM),
blood, and spinal fluid ofpatients, culture ofthe organism is a low-yield procedure
[1,2]. Direct visualization of the spirochete in patient specimens has also been dif-
ficult [1]. Therefore, determination ofantibody titers is currentlythebestlaboratory
method for diagnosis [1,3]. We report here the antibody response in Lyme disease
determined by indirect immunofluorescence and anewlydeveloped ELISA. In addi-
tion, we describe absorption studies of cross-reactive antibodies from patients with
other spirochetal infections. Finally, to further characterize the immunospecificity
ofthe antibody response in Lyme disease patients, we present data regarding the im-
munoprecipitation of in vivo 35S-methionine-labeled I. dammini spirochetal an-
tigens.
ANTIBODY RESPONSE BY IMMUNOFLUORESCENCE
Initially, antibody studies were done by indirect immunofluorescence alone. I.
dammini spirochetes, strain G39/40 isolated from ticks in Connecticut, were fixed
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All rights of reproduction in any form reserved.to individual wells of microtiter slides by freezing at -70°C. Indirect im-
munofluorescence was performed by standard methods [1]. Each slide was overlaid
with twofold dilutions of patient serum and subsequently with fluorescinated an-
tihuman IgM or IgG. All slides were read blindly and titers were reported as
reciprocals of dilution.
IgM and IgG antibody titers were done in 135 patients with Lyme disease and 80
control subjects (Fig. 1) [1]. The patients with Lyme disease included 80 people with
ECM: 40 with ECM alone and 40 with ECM complicated by carditis and/or neuritis
(30 patients) and often arthritis (25 patients). Twenty additional patients with
neurologic or cardiac involvement and 35 with arthritis who did not have earlier
samples taken were also studied. The control subjects included patients with active
inflammatory arthritis, acute infectious mononucleosis, and healthy individuals
from Connecticut and Georgia. Specific IgM titers in Lyme disease werehighest dur-
ing the third through the sixth week after onset of ECM. Titers gradually declined
thereafter, but a significant number of patients still had titers >64 during neuritis,
carditis, or arthritis. Specific IgG titers were lowest during ECM, increased during
neuritis or carditis, and were highest months later when arthritis was present.
Among the patients with neurologic, cardiac, or joint involvement, 94 percent had
IgG titers >64, and all 60 of the patients with arthritis had such titers. Of the 80
control subjects, onlythree with infectious mononucleosis had an IgM titer >64 and
none had an IgG titer >64.
ANTIBODY RESPONSE BY ELISA
To extend these findings, we developed an ELISA to measure specific IgM and
IgG antibodies in Lyme disease [4]. I. dammini spirochetes, strain G39/40, were
grown to late log phase in modified Kelly's medium [5], harvested by centrifugation,
washed, and sonicated on ice. This lysate was used as the antigen for solid phase
coating. The ELISA was performed by standard techniques [6]. Endpoint titers of
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FIG. 1. Antibody titers against
the I. damminispirochete in serum
samples from 135 patients with dif-
ferent clinical manifestations of
Lyme disease, as compared with
those found in 80 control subjects.
The heavy bar shows thegeometric
mean titer for each group; the
shaded areas indicate the range of
titers generally observed in control
subjects. Reprinted, by permission
of the New England Journal of
Medicine [1].
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unknown sera were determined at optical density values that were two standard
deviations above those of 17 normal control sera.
IgM and IgG antibody titers were determined in 12 patients with severe Lyme
disease in whom serial sera were available from aprolonged period: generally during
early disease (ECM), during neuritis and/or arthritis, and after remission. Forty-one
serial specimens from these 12 patients were tested. Controls included 40 patients
with rheumatoid arthritis, systemic lupus, acute infectious mononucleosis, and nor-
mal subjects. None of the controls, including ten patients with infectious mononu-
cleosis, had IgM or IgG titers >200; titers >200 were thereforeconsidered elevated.
In patients with Lyme disease, specific IgM titers were highest during ECM, and 11
of the 12 patients had titers >200. Titers declined thereafter, but eight patients had
elevated titers during neuritis (4 to 16 weeks after onset of ECM) and four still had
elevated titers during arthritis (4 to 29 months after onset of ECM). Specific IgG
levels were lowest during ECM, increased during neuritis, were highest months later
when arthritis was present, and remained high after 2 to 16 months of remission.
Nine ofthe patients had IgG titers >200 during neuritis, and all had such titers dur-
ing arthritis.
Most recently, we also examined the antibody response by ELISA in 32 patients
seen early after onset ofECM. All were treated with antibiotics and did not develop
neurologic, cardiac, or joint disease. Ten patients had niild illness, usually ECM
alone, and twenty-two had more severe illness-multiple skin lesions, musculoskele-
tal symptoms, and/or abnormal liver function tests. Three patients with mild disease
(ECM alone) had an elevated IgM response during acute disease or convalescence,
and only one had an elevated IgG response. In contrast, patients with more severe
disease were more likely to have positive IgM responses, although twelve patients
still had titers <200 during acute disease or convalescence. IgG responses were
often low during acute disease, but seven patients had a positive response during
convalescence.
We conclude from these data that the IgM response, although often absent in
early localized Lyme disease, is generally present in patients with ECM who are
more ill. The maximal response occurs after three to six weeks, and then declines.
However, it may persist in later disease. Although the mechanism of the continued
elevation of specific IgM is unclear, its persistence implies ongoing antigenic
stimulation of the immune system, perhaps by an intact spirochete. The IgG
response, often absent in early disease, is nearly always present during neuritis, car-
ditis, or arthritis, and may remain elevated after months of remission. Either an-
tibody response can be aborted by early antibiotic therapy.
COMPARISON OF ELISA AND IMMUNOFLUORESCENCE
To compare our ELISA and immunofluorescence tests, we determined IgM and
IgG titers by both methods on 41 samples from Lyme disease patients. Although
there was a significant correlation oftiters betweenthe two methods, theELSIA was
more sensitive and specific than immunofluorescence. In particular, the false-
positive IgM responses seen in certain infectious mononucleosis samples by im-
munofluorescence were not found in the same samples when tested by ELISA.
CORRELATION OF TOTAL AND SPECIFIC IgM
We also investigated the correlation between total and specific IgM levels in Lyme
disease patients. In 41 serum samples from various stages of Lyme disease, specific
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IgM, determined by ELISA, correlated directly with total IgM (r = 0.62,
p <0.001, slope = 101). Since total serum IgM reflects disease activity [7], this
finding implies that the persistence ofspecific IgM antibodies mayalso be associated
with more severe disease. In contrast, there was no correlation between total and
specific IgG.
CROSS-REACTIVE ANTIBODIES
Next, to look for cross-reactive antibodies in other spirochetal infections, we
determined IgG titers by ELISA in sera from patients with louse-borne relapsing
fever, syphilis, or leptospirosis, and compared them to titers in Lyme disease pa-
tients. Using the I. dammini spirochetal lysate as the solid-phase antigen, serologic
cross-reactivity against the L dammini spirochete was found in these spirochetal in-
fections, particularly relapsing fever and syphilis. After adsorption with a sonicate
ofBorrelia hermsii, similar to the FTA-adsorbed test for syphilis [8], sera from pa-
tients with relapsing fever, syphilis, and leptospirosis generally had a fourfold or
greater reduction in titer, compared to unabsorbed sera. Titers of Lyme disease sera
were also lowered by absorption, although the decrease was usuallytwofold. Thus it
currently seems impractical to use this adsorption step as a refinement of our
original ELISA procedure. Lyme disease can usuallybedistinguished clinically from
relapsing fever, syphilis, and leptospirosis. If confusion exists in separating Lyme
disease from syphilis, VDRLs are positive only in syphilis [9].
POLYPEPTIDES OF THE LYME SPIROCHETE
Preliminary attempts to characterize the immunospecificity ofthe IgG antibodies
in Lyme patients were also made. L dammini spirochetes (strain G39/40) in 7.5 ml
ofmodified Kelly's medium werepulse-labeled for 12 hours bythe addition of 1 mCi
of 35S-methionine at late log phase growth. After collection by centrifugation and
after extensive washing in cold 0.01 M PBS/5mM magnesium chloride, the
organisms were sonicated on ice. Intact organisms and large cellular debris were
then removed by centrifugation at 10,000 g for 30 minutes at 4°C. The 35S-methi-
onine-labeled crude supernatant fraction, after immunoprecipitation with patient
sera and staphylococcal protein A [10], was then subjected to polyacrylamide gel
electrophoresis [11], followed by 2,5-diphenyloxazole fluorography and autora-
diography. By this method, spirochetal polypeptides with monomeric molecular
weights of62, 60, 47, 37, 22, 18, and 15 kDa wereidentified with sera from Lyme ar-
thritis patients. Control sera from normal patients and patients with active inflam-
matory arthritis did not precipitate these antigens. These preliminary experiments
demonstrate the spirochetal antigens responsible for the IgG response in chronic
Lyme disease and may provide a basis for the delineation ofthe most important an-
tigens of Lyme arthritis.
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